What is ConvaTec Group Plc (CNVVF)?

ConvaTec Group Plc (CNVVF) is a stock in the Healthcare sector, Medical - Instruments & Supplies industry. View full analysis on Stocks360.

What is the current price of CNVVF?

The current price of CNVVF is $3.22. Prices are updated in real time on Stocks360.

What is CNVVF's price-to-earnings (PE) ratio?

CNVVF's trailing twelve-month PE ratio is 51.61, based on current price and earnings per share data available on Stocks360.

What is CNVVF's market capitalization?

CNVVF's market capitalization is $6,146,544,677.00, placing it in the mid-cap tier.

Does CNVVF pay a dividend?

Yes. CNVVF has a trailing twelve-month dividend yield of 0.02%. Dividend data is sourced from financial market providers and displayed on Stocks360.

ConvaTec Group Plc (CNVVF)

Stock analysis · OTC · Healthcare · Medical - Instruments & Supplies

$3.22

Market Cap

$6.15B

PE (TTM)

51.61

EPS (TTM)

N/A

Dividend Yield

2.28%

Beta

0.90

Day Range

$3.15 – $3.22

52-wk Range

$2.30 – $3.65

Avg Volume

N/A

Volume

1.50K

ConvaTec Group Plc (CNVVF) is a publicly traded company in the Healthcare sector. Latest price: $3.22. Market cap $6.15B. Trailing PE 51.61. Dividend yield 2.28%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 11 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $3.05 2026-10-28 · $3.22 (+5.57%)

Earnings

Most Recent

Aug 4, 2026

EPS $0.09 vs est. $0.08

Beat by $0.00

Next Earnings

Feb 23, 2027

EPS estimate $0.12

Proprietary Signals

Signal snapshot temporarily unavailable.

About ConvaTec Group Plc

ConvaTec Group Plc is a global medical technology company focused on creating, producing, and distributing a wide array of healthcare products. Their offerings span several key areas: Advanced Wound Management: This includes specialized dressings and skincare solutions for treating both acute and chronic wounds, which can arise from conditions like diabetes, prolonged immobility, venous disease, traumatic injuries, burns, or surgical interventions. Ostomy Care: The company provides vital devices, accessories, and support services for individuals who have undergone ostomy procedures, often necessitated by conditions such as colorectal or bladder cancer, inflammatory bowel disease, or obesity. Continence and Critical Care: This division offers intermittent urinary catheters and related products to help manage urinary continence issues for patients with spinal cord injuries, multiple sclerosis, spina bifida, and other urological conditions. It also supplies a range of devices crucial for intensive care units and broader hospital settings. Specialized Monitoring and Management Systems: ConvaTec develops advanced systems for managing acute fecal incontinence, meticulously monitoring ur…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	51.61×
P/S (TTM)	2.52×
P/B	4.45×
P/FCF (TTM)	32.70×
EV / EBITDA	12.61×
EV / Sales	3.18×
Earnings Yield	1.94%
Free Cash Flow Yield	3.06%
Dividend Yield	2.28%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$7.91B
Revenue (TTM)	$2.49B
Net Income (TTM)	$121.44M
Free Cash Flow (TTM)	$199.62M
Net Debt	$1.65B
Working Capital	$482.49M
Gross Margin	55.07%
Operating Margin	16.16%
Net Margin	4.99%
Return on Equity	8.40%
Return on Invested Capital	9.44%